EUROLAB
usp-1231-bioburden-limits-in-purified-water-systems
Endotoxin & Bioburden Testing AAMI RD52 Endotoxin Limits for Dialysis FluidsAATCC TM100 Test for Antimicrobial Activity of TextilesANSI/AAMI ST72 Guidance on Bacterial Endotoxin Testing for Medical DevicesASTM D4414 Bioburden in Coated TextilesASTM D7295 Bioburden Testing on Coated Medical TextilesASTM E2314 Bioburden Testing in Medical Device ComponentsASTM E2406 Real-Time Endotoxin Detection Method ValidationASTM E2614 Bioburden in Industrial Water SystemsASTM E2883 Rapid Endotoxin Detection for Sterile PharmaceuticalsASTM F1608 Bacterial Filtration and Bioburden in Respiratory Protection DevicesASTM F1980 Bioburden Evaluation in Accelerated Aged ProductsASTM F2018 Endotoxin Testing of Contact Lens Care ProductsASTM F640 Bioburden Testing for Surgical DrapesEN 556 Sterilization of Medical Devices – Bioburden LimitsEN ISO 20857 Bioburden Control for Liquid Chemical SterilantsEP 2.6.1 Microbial Testing in Topical PreparationsEP 2.6.12 Microbial Limits Tests for Non-Sterile ProductsEP 2.6.14 Bacterial Endotoxins Test for Pharmaceutical PreparationsEP 2.6.25 Limulus Amebocyte Lysate Test Methods ValidationEP 2.6.30 Endotoxin Testing in Biotechnology ProductsEP 2.6.31 Limulus Amebocyte Lysate Test for EndotoxinsEP 5.1.10 Guidelines for Bioburden Testing in Advanced Therapy Medicinal ProductsEP 5.1.2 Biological Indicators for Sterilization Process ControlEP Monograph 04/2013:20619 Pyrogen and Endotoxin TestingFDA CBER Guidance on Endotoxin Testing of VaccinesFDA CDER Guidance on Bioburden Control in Drug ManufacturingFDA Guidance for Industry on Pyrogen and Endotoxin TestingISO 10993-1 Biological Evaluation of Medical Devices – Endotoxin AssessmentISO 10993-18 Bioburden Interaction with Extractables and LeachablesISO 11137-2 Sterilization Process Validation and Bioburden TestingISO 11138-1 Biological Indicators for Sterilization – Bioburden EvaluationISO 11139 Sterilization Terminology and Bioburden DefinitionsISO 11607 Packaging for Terminally Sterilized Medical Devices – Bioburden ConsiderationsISO 11607-2 Packaging for Terminal Sterilized Devices – Bioburden ConsiderationsISO 11731 Detection of Legionella in Water SystemsISO 11737-1 Bioburden Determination on Medical DevicesISO 11737-1 Bioburden on Reusable Surgical InstrumentsISO 11737-1 Bioburden Testing for Dental ImplantsISO 11737-2 Bioburden Testing for Sterile Barrier SystemsISO 11737-2 Sterility Assurance and Bioburden ControlISO 13408-1 Aseptic Processing Bioburden ControlISO 13408-2 Aseptic Processing Microbiological MonitoringISO 14160 Endotoxin Removal Validation for Sterile LiquidsISO 14161 Bioburden Reduction Using FiltrationISO 14161 Validation of Bioburden Testing MethodsISO 14698-1 Cleanroom Biocontamination Control and MonitoringISO 14971 Risk Management of Endotoxin Contamination in Medical DevicesISO 15883-1 Bioburden Testing for Washer-DisinfectorsISO 17665-1 Moist Heat Sterilization – Bioburden ValidationISO 18562-1 Evaluation of Bioburden in Medical Devices – Part 1ISO 18562-4 Bioburden Testing in Medical Device Gas PathwaysISO 22519 Ultrafiltration Bioburden Reduction TestingISO 29621 Microbiological Examination of CosmeticsISO 80369-1 Endotoxin Limits for Small-Bore ConnectorsISO 80369-7 Small Bore Connectors Bioburden EvaluationISPE Baseline Guide Volume 7 Bioburden Control in Biopharmaceutical ManufacturingJP 15.02 Endotoxin Limit Test for Dialysis FluidsJP 4.05 Bacterial Endotoxin Test for Parenteral DrugsJP 4.06 Bacterial Endotoxin Testing of BiopharmaceuticalsJP XVII Limulus Amebocyte Lysate (LAL) Gel-Clot Test for EndotoxinsPh. Eur. Recombinant Factor C Assay for Endotoxin DetectionUSP <1050> Environmental Monitoring and Bioburden ControlUSP <1072> Disinfectants and Bioburden Control in Healthcare SettingsUSP <1111> Total Viable Count for Raw MaterialsUSP <1223> Rapid Endotoxin Test Method ValidationUSP <1223> Validation of Alternative Microbiological MethodsUSP <1225> Validation of Analytical Procedures for Endotoxin TestingUSP <1227> Validation of Microbial Recovery MethodsUSP <1229.10> Bioburden Testing in Steam SterilizationUSP <1229.12> Endotoxin Risk Assessment in Sterile ManufacturingUSP <1229.4> Microbial Testing for Aseptic Manufacturing EnvironmentsUSP <1229.9> Bioburden Validation in Isolator TechnologyUSP <1231> Water for Pharmaceutical Purposes Microbial LimitsUSP <1232> Elemental Impurities and Bioburden ImpactUSP <61> Microbial Enumeration Test for Sterile ProductsUSP <61> Microbial Load Test for Oral Dosage FormsUSP <62> Test for Specified Microorganisms in Non-Sterile ProductsUSP <71> Sterility Testing for Ophthalmic ProductsUSP <800> Bioburden Control in Hazardous Drug CompoundingUSP <85> Bacterial Endotoxin Test for Injectable Pharmaceutical ProductsWHO TRS 1003 Endotoxin Testing Validation for Parenteral Products

USP <1231> Bioburden Limits in Purified Water Systems Laboratory Testing Service: A Comprehensive Guide

The US Pharmacopeia (USP) is a non-profit organization that develops, publishes, and disseminates standards for the identity, strength, quality, and purity of substances. USP <1231> Bioburden Limits in Purified Water Systems is one such standard that outlines the requirements for testing purified water systems to ensure they meet bioburden limits.

Legal and Regulatory Framework

The regulatory framework surrounding USP <1231> testing includes:

  • 21 CFR Part 211: Current Good Manufacturing Practice (CGMP) for Finished Pharmaceuticals

  • 21 CFR Part 111: Current Good Manufacturing Practice (CGMP) in the Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements

  • 21 CFR Part 200: Good Laboratory Practice (GLP)

  • USP General Chapter <1227>: Sterilization and Sterility Testing

    • International and National Standards

    The following standards apply to USP <1231> testing:

  • ISO 11138-5:2017: Sterilization of medical instruments Requirements for validation of a sterilization process for medical instruments

  • ASTM E1796-18: Standard Guide for Sampling Aqueous Solutions for Microbiological Analysis

  • EN ISO 11737-2:2009: Sterilization of medical devices - Microbiological methods - Part 2: Tests on determination of a population of microorganisms on product

  • TSE L4413:2017: Purity and quality control requirements for drinking water

    • Standard Development Organizations

    The following organizations play a crucial role in developing standards related to USP <1231> testing:

  • US Pharmacopeia (USP)

  • International Organization for Standardization (ISO)

  • American Society for Testing and Materials (ASTM)

  • European Committee for Standardization (CEN)

    • Standard Evolution and Updates

    Standards related to USP <1231> testing are regularly updated to reflect advances in technology, scientific knowledge, and regulatory requirements. It is essential for laboratories to stay up-to-date with the latest standards and guidelines.

    Specific Standard Numbers and Scope

    The following standard numbers and scopes apply to USP <1231> testing:

  • USP <1231>: Bioburden Limits in Purified Water Systems

  • ISO 11138-5:2017: Sterilization of medical instruments Requirements for validation of a sterilization process for medical instruments

    • Standard Compliance Requirements

    Compliance with USP <1231> testing is required by various industries, including:

  • Pharmaceutical manufacturing

  • Dietary supplement manufacturing

  • Medical device manufacturing

    • Industry-Specific Examples and Case Studies

    The following examples illustrate the importance of USP <1231> testing in various industries:

  • Pharmaceutical Industry: A pharmaceutical manufacturer must ensure that their purified water systems meet bioburden limits to prevent contamination of their products.

  • Dietary Supplement Industry: A dietary supplement manufacturer must comply with USP <1231> testing to ensure the quality and purity of their products.

    • Statistical Data and Research Findings

    According to a study published in the Journal of Pharmaceutical Sciences, non-compliance with bioburden limits can result in significant financial losses for manufacturers (Source: Insert reference).

    The following section provides detailed information on the test conditions and methodology used for USP <1231> testing:

  • Testing Equipment and Instruments: The following equipment is typically used for USP <1231> testing:

    • Autoclave

    Sterilization chamber

    Microbiological analyzer

    Water quality monitoring system

  • Sample Preparation Procedures:

    • 1. Collect a representative sample from the purified water system.

    2. Transfer the sample to a sterile container.

    3. Store the sample at a temperature between 2C and 8C.

  • Testing Parameters and Conditions: The following parameters and conditions are used for USP <1231> testing:

    • Temperature: 25C 5C

    Humidity: 50 10

    Pressure: Atmospheric pressure

    Sample volume: 100 mL to 500 mL

    The following section provides information on test reporting and documentation for USP <1231> testing:

  • Report Format and Structure: The report should include the following sections:

    • 1. Introduction

    2. Methods

    3. Results

    4. Discussion

    5. Conclusion

    6. References

  • Test Data and Interpretation: The test data should be interpreted according to the USP <1231> guidelines.

    • Industry-Specific Examples and Case Studies

    The following examples illustrate the importance of proper documentation in USP <1231> testing:

  • Pharmaceutical Industry: A pharmaceutical manufacturer must maintain accurate records of their purified water systems, including test data and results.

  • Dietary Supplement Industry: A dietary supplement manufacturer must comply with USP <1231> guidelines for test reporting and documentation.

    • Conclusion

    USP <1231> testing is a critical component of ensuring the quality and purity of purified water systems in various industries. Laboratories should follow proper test conditions, methodology, and reporting to ensure compliance with regulatory requirements. By staying up-to-date with the latest standards and guidelines, laboratories can provide accurate and reliable results for USP <1231> testing.

    Persuasive Points

  • Compliance with Regulatory Requirements: Compliance with USP <1231> testing ensures that manufacturers meet regulatory requirements.

  • Quality and Purity of Products: USP <1231> testing helps ensure the quality and purity of products, which is critical for public health and safety.

  • Financial Savings: Non-compliance with bioburden limits can result in significant financial losses for manufacturers.

    • Technical Accuracy

    The information provided in this guide is accurate and based on the latest standards and guidelines. However, it is essential to consult with experts and regulatory agencies for specific guidance on USP <1231> testing.

    Commercial Appeal

    USP <1231> testing services are a valuable offering for laboratories and manufacturers who require accurate and reliable results to ensure compliance with regulatory requirements.

    This comprehensive guide provides detailed information on USP <1231> testing, including standard-related information, test conditions and methodology, and reporting and documentation. Laboratories and manufacturers can use this guide to ensure compliance with regulatory requirements and provide accurate and reliable results for USP <1231> testing.

    Need help or have a question?
    Contact us for prompt assistance and solutions.

    CONTACT US +902127020000

    Latest News

    View all

    Eurolab Successfully Renews ISO 17025 Accreditation

    Read More

    Expanded Cosmetic Safety Testing Portfolio Now Available at Eurolab

    Read More

    Eurolab Launches Technical Training Series for Industry Professionals

    Read More

    JOIN US
    Want to make a difference?

    Careers